Odds ratios and 95% CI of rheumatic evolution according to parity and pregnancy outcome
| . | OR (95% CI) . | ||
|---|---|---|---|
| . | Negative . | Non-criteria rheumatic disease . | Definite rheumatic disease . |
| One viable pregnancy after inclusion | Baseline | 4.6 (2.1, 10.3) | 4.9 (2.3, 10.4) |
| Two or more viable pregnancies after inclusion | Baseline | 2 (0.4, 9.4) | 5 (1.5, 17.3) |
| Overall viable pregnancies | Baseline | 4.1 (1.9, 8.9) | 4.9 (2.4, 10.0) |
| Preeclampsia | Baseline | 1.2 (0.3, 5.6) | 4.3 (1.2, 14.8) |
| . | OR (95% CI) . | ||
|---|---|---|---|
| . | Negative . | Non-criteria rheumatic disease . | Definite rheumatic disease . |
| One viable pregnancy after inclusion | Baseline | 4.6 (2.1, 10.3) | 4.9 (2.3, 10.4) |
| Two or more viable pregnancies after inclusion | Baseline | 2 (0.4, 9.4) | 5 (1.5, 17.3) |
| Overall viable pregnancies | Baseline | 4.1 (1.9, 8.9) | 4.9 (2.4, 10.0) |
| Preeclampsia | Baseline | 1.2 (0.3, 5.6) | 4.3 (1.2, 14.8) |
OR and 95% CI were obtained by multinomial logistic regression including rheumatological sequelae as outcome (negative, non-criteria rheumatic disease, definite rheumatic disease) and age of the subjects at enrolment, number of viable pregnancies after the enrolment (no, one, two or more) and preeclampsia during index of following pregnancies (yes, no) as exposure variables.
Odds ratios and 95% CI of rheumatic evolution according to parity and pregnancy outcome
| . | OR (95% CI) . | ||
|---|---|---|---|
| . | Negative . | Non-criteria rheumatic disease . | Definite rheumatic disease . |
| One viable pregnancy after inclusion | Baseline | 4.6 (2.1, 10.3) | 4.9 (2.3, 10.4) |
| Two or more viable pregnancies after inclusion | Baseline | 2 (0.4, 9.4) | 5 (1.5, 17.3) |
| Overall viable pregnancies | Baseline | 4.1 (1.9, 8.9) | 4.9 (2.4, 10.0) |
| Preeclampsia | Baseline | 1.2 (0.3, 5.6) | 4.3 (1.2, 14.8) |
| . | OR (95% CI) . | ||
|---|---|---|---|
| . | Negative . | Non-criteria rheumatic disease . | Definite rheumatic disease . |
| One viable pregnancy after inclusion | Baseline | 4.6 (2.1, 10.3) | 4.9 (2.3, 10.4) |
| Two or more viable pregnancies after inclusion | Baseline | 2 (0.4, 9.4) | 5 (1.5, 17.3) |
| Overall viable pregnancies | Baseline | 4.1 (1.9, 8.9) | 4.9 (2.4, 10.0) |
| Preeclampsia | Baseline | 1.2 (0.3, 5.6) | 4.3 (1.2, 14.8) |
OR and 95% CI were obtained by multinomial logistic regression including rheumatological sequelae as outcome (negative, non-criteria rheumatic disease, definite rheumatic disease) and age of the subjects at enrolment, number of viable pregnancies after the enrolment (no, one, two or more) and preeclampsia during index of following pregnancies (yes, no) as exposure variables.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
